Regulatory overview:MDR is EU medical device product legislation setting lifecycle safety, performance, evidence and economic operator responsibilities. It does not cover all health products. Device status requires consideration of definitions, intended purpose and boundaries.

Regulatory purpose and product scope

2017/745 addresses device safety and performance and patient and user protection. The medical device definition concerns intended medical purpose and principal mode of action. Annex XVI also covers specified products without a medical purpose.

Risk classification and essential requirements

Annex VIII rules classify devices as I, IIa, IIb or III based on intended purpose and relevant rules, rather than name or sales channel alone. Annex I sets general safety and performance requirements.

Principal obligation structure

Manufacturers bear quality management, risk management, technical documentation, clinical evaluation, post-market surveillance and vigilance responsibilities. Non-EU manufacturers, authorised representatives, importers and distributors have different obligations. Contractual names alone cannot replace legal roles.

Relationship with IVDR, standards and databases

IVDs are principally governed by IVDR. Quality management system standards can support relevant work but cannot replace product legislation. Actor or product registration in EUDAMED is also distinct from the device itself meeting regulatory requirements.

Application dates and transition

MDR has applied since 2021-05-26. Legacy device transition depends on product circumstances, certificates, quality systems and other statutory conditions. Distinguish regulatory application from transitional arrangements allowing specific devices to continue being made available. This article does not reduce all products to one deadline.

Official sources and applicability limits

The following are official EU legislation and implementation explanations. This article introduces general structure and applicability boundaries. Legal effect rests with Official Journal texts and amendments; Commission guidance provides supporting interpretation. Where official topic pages have no separate publication date, this review date is the access date.